SCHEMBL893473

SCHEMBL893473

CCCCN(CCCC)c1ncnc(N(CCCC)CCCC)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
HTT P42858 1/20 0.45
NCOA1 Q15788 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
CRHR1 P34998 3/20 0.41
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
LMNA P02545 5/20 0.36
PKM P14618 1/20 0.36
ELANE P08246 1/20 0.35
DNM2 P50570 2/20 0.34
SLC29A1 Q99808 2/20 0.34
UTS2R Q9UKP6 1/20 0.34
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
GFER P55789 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28377129 0.88 SMN1; SMN2 (0.41) SMN1; SMN2HTTNCOA1NCOA3CRHR1
SCHEMBL13818456 0.88 CRHR1 (0.46) SMN1; SMN2HTTNCOA1NCOA3CRHR1
SCHEMBL9417739 0.87 SMN1; SMN2 (0.40) SMN1; SMN2HTTNCOA1NCOA3CRHR1
SCHEMBL28875638 0.87 SMN1; SMN2 (0.40) SMN1; SMN2HTTNCOA1NCOA3CRHR1
SCHEMBL27528977 0.87 SMN1; SMN2 (0.40) SMN1; SMN2HTTNCOA1NCOA3CRHR1
SCHEMBL11813260 0.85 MAPT (0.45) SMN1; SMN2HTTNCOA1NCOA3MAPT
SCHEMBL5355585 0.84 MAPT (0.50) SMN1; SMN2HTTNCOA1NCOA3CRHR1
SCHEMBL3182836 0.83 HTT (0.41) SMN1; SMN2HTTNCOA1NCOA3CRHR1
SCHEMBL20873657 0.80 SMN1; SMN2 (0.48) SMN1; SMN2HTTNCOA1NCOA3LMNA
SCHEMBL7693415 0.80 DNM2 (0.35) SMN1; SMN2HTTNCOA1NCOA3CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114080420-B Tabletting of specific polymeric stabilizers 巴斯夫欧洲公司 2024-10-01 CN claimed
CN-101903449-B Flame retardant compositions containing sterically hindered amines BASF SE 2013-05-22 CN claimed
EP-2451869-A1 PHENYLPHOSPHONATE FLAME RETARDANT COMPOSITIONS BASF SE (DE) 2012-05-16 EP claimed
WO-2011003773-A1 PHENYLPHOSPHONATE FLAME RETARDANT COMPOSITIONS BASF SE (DE) 2011-01-13 WO claimed
US-20030120077-A1 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES PETER (US) 2003-06-26 US claimed
US-6403681-B2 STABILIZER FOR PLASTICS CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-11 US claimed
US-20020058735-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES PETER (US) 2002-05-16 US claimed
US-20020040145-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2002-04-04 US claimed
US-20010034449-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-10-25 US claimed
US-20010031872-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-10-18 US claimed
US-20010018520-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-08-30 US claimed
US-6271377-B1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORPORATION 2001-08-07 US claimed
US-6391949-B1 None US disclosed
WO-2024117646-A1 THERMOPLASTIC RESIN COMPOSITION FOR LIGHT-EMITTING DIODE REFLECTOR AND MOLDED PRODUCT COMPRISING SAME 롯데케미칼 주식회사 2024-06-06 WO disclosed
EP-3877463-A1 POLYETHYLENE WITH ADDITIVES FOR INCREASED ENVIRONMENTAL STRESS CRACK RESISTANCE SABIC Global Technologies B.V. (NL) 2021-09-15 EP disclosed
CN-106574090-B 3- phenylbenzofuran -2- ketone diphosphorous acid ester derivant as stabilizer 巴斯夫欧洲公司 2019-11-19 CN disclosed
US-20010016658-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-08-23 US disclosed
US-6271377-B1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORPORATION 2001-08-07 US disclosed
EP-0996669-A1 FLAME RETARDANT COMPOSITIONS Ciba SC Holding AG (CH) 2000-05-03 EP disclosed
WO-1999000450-A1 FLAME RETARDANT COMPOSITIONS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1999-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020040145-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 SMN1; SMN2 595/4885HTT 178/4885NCOA1 1556/4885
US-20020058735-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith OGG1, HAO2, POLH SMN1; SMN2 611/4885HTT 186/4885NCOA1 1626/4885
US-20010016658-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 SMN1; SMN2 595/4885HTT 178/4885NCOA1 1556/4885
US-20010034449-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 SMN1; SMN2 595/4885HTT 178/4885NCOA1 1556/4885
US-20030120077-A1 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith OGG1, POLH, OGFOD1 SMN1; SMN2 552/4885HTT 233/4885NCOA1 1891/4885
US-20010018520-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 SMN1; SMN2 595/4885HTT 178/4885NCOA1 1556/4885
US-20010031872-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 SMN1; SMN2 595/4885HTT 178/4885NCOA1 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.